These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 34630912)

  • 21. Role of Mitochondria in Alcoholic Liver Disease.
    García-Ruiz C; Kaplowitz N; Fernandez-Checa JC
    Curr Pathobiol Rep; 2013 Sep; 1(3):159-168. PubMed ID: 25343061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alcohol, microbiome, life style influence alcohol and non-alcoholic organ damage.
    Neuman MG; French SW; Zakhari S; Malnick S; Seitz HK; Cohen LB; Salaspuro M; Voinea-Griffin A; Barasch A; Kirpich IA; Thomes PG; Schrum LW; Donohue TM; Kharbanda KK; Cruz M; Opris M
    Exp Mol Pathol; 2017 Feb; 102(1):162-180. PubMed ID: 28077318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
    Wang M; Ma LJ; Yang Y; Xiao Z; Wan JB
    Crit Rev Food Sci Nutr; 2019; 59(sup1):S116-S129. PubMed ID: 30580553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Linking Pathogenic Mechanisms of Alcoholic Liver Disease With Clinical Phenotypes.
    Nagy LE; Ding WX; Cresci G; Saikia P; Shah VH
    Gastroenterology; 2016 Jun; 150(8):1756-68. PubMed ID: 26919968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogenesis and pathways: nonalcoholic fatty liver disease & alcoholic liver disease.
    Robinson KE; Shah VH
    Transl Gastroenterol Hepatol; 2020; 5():49. PubMed ID: 33073044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathophysiological Aspects of Alcohol Metabolism in the Liver.
    Hyun J; Han J; Lee C; Yoon M; Jung Y
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intestinal HIF-1α deletion exacerbates alcoholic liver disease by inducing intestinal dysbiosis and barrier dysfunction.
    Shao T; Zhao C; Li F; Gu Z; Liu L; Zhang L; Wang Y; He L; Liu Y; Liu Q; Chen Y; Donde H; Wang R; Jala VR; Barve S; Chen SY; Zhang X; Chen Y; McClain CJ; Feng W
    J Hepatol; 2018 Oct; 69(4):886-895. PubMed ID: 29803899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatocyte-derived macrophage migration inhibitory factor mediates alcohol-induced liver injury in mice and patients.
    Marin V; Poulsen K; Odena G; McMullen MR; Altamirano J; Sancho-Bru P; Tiribelli C; Caballeria J; Rosso N; Bataller R; Nagy LE
    J Hepatol; 2017 Nov; 67(5):1018-1025. PubMed ID: 28647568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting the gut microbiota to treat alcoholic liver diseases: evidence and promises.
    Leclercq S; de Timary P; Stärkel P
    Acta Gastroenterol Belg; 2020; 83(4):616-621. PubMed ID: 33321019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current Management and Future Treatment of Alcoholic Hepatitis.
    Mitchell MC; Kerr T; Herlong HF
    Gastroenterol Hepatol (N Y); 2020 Apr; 16(4):178-189. PubMed ID: 34035720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dysregulated cytokine metabolism, altered hepatic methionine metabolism and proteasome dysfunction in alcoholic liver disease.
    McClain C; Barve S; Joshi-Barve S; Song Z; Deaciuc I; Chen T; Hill D
    Alcohol Clin Exp Res; 2005 Nov; 29(11 Suppl):180S-8S. PubMed ID: 16344606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alcoholic-related liver disease: pathogenesis, management and future therapeutic developments.
    Argemi J; Ventura-Cots M; Rachakonda V; Bataller R
    Rev Esp Enferm Dig; 2020 Nov; 112(11):869-878. PubMed ID: 33054302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gut-liver axis in alcoholic liver disease.
    Szabo G
    Gastroenterology; 2015 Jan; 148(1):30-6. PubMed ID: 25447847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Common pathogenic mechanism in development progression of liver injury caused by non-alcoholic or alcoholic steatohepatitis.
    Nagata K; Suzuki H; Sakaguchi S
    J Toxicol Sci; 2007 Dec; 32(5):453-68. PubMed ID: 18198478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inflammation in alcohol-associated liver disease progression.
    Lotersztajn S; Riva A; Wang S; Dooley S; Chokshi S; Gao B
    Z Gastroenterol; 2022 Jan; 60(1):58-66. PubMed ID: 35042254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune mechanisms in alcoholic liver disease.
    Albano E; Vidali M
    Genes Nutr; 2010 Jun; 5(2):141-7. PubMed ID: 19809845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of the endocannabinoid system in alcoholic liver disease.
    Siegmund SV
    Dig Dis; 2010; 28(6):751-5. PubMed ID: 21525760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of spleen tyrosine kinase activation ameliorates inflammation, cell death, and steatosis in alcoholic liver disease.
    Bukong TN; Iracheta-Vellve A; Saha B; Ambade A; Satishchandran A; Gyongyosi B; Lowe P; Catalano D; Kodys K; Szabo G
    Hepatology; 2016 Oct; 64(4):1057-71. PubMed ID: 27302565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alcoholic liver disease: focus on prodromal gut health.
    Park B; Lee HR; Lee YJ
    J Dig Dis; 2016 Aug; 17(8):493-500. PubMed ID: 27356233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microbiome dysbiosis and alcoholic liver disease
    Li F; McClain CJ; Feng W
    Liver Res; 2019 Dec; 3(3-4):218-226. PubMed ID: 33868760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.